From the Department of Orthopaedic Surgery, Brigham and Women's Hospital (Dr. Chen), Division of Adult Reconstruction and Total Joint Arthroplasty, Department of Orthopaedic Surgery, Harvard Medical School (Dr. Chen), Clinical Microbiology Laboratories, Department of Pathology, Beth Israel Deaconess Medical Center (Dr. Riedel), and Department of Pathology, Harvard Medical School (Dr. Riedel), Boston, MA.
None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Chen and Dr. Riedel.
Dr. Chen or an immediate family member serves as a paid consultant to 3M, the American Medical Foundation, Avanos, bOne, ConvaTec, Ethicon, GLG, Guidepoint, Heraeus, Irrimax, Pfizer, PhagoMed, Recro, and Stryker; has stock or stock options held in bOne, GraftWorx, Hyalex, Irrimax, Joint Purification Systems, and Sonoran; has received research or institutional support from Avanos; and serves as a board member, owner, officer, or committee member of AAOS, AJRR, American Association of Hip and Knee Surgeons, European Knee Association, International Congress for Joint Reconstruction, and Musculoskeletal Infection Society. Dr. Riedel or an immediate family member serves as a paid consultant to Lumos Diagnostics; serves as a paid consultant and member of Clinical Advisory Board to OpGen; serves as a advisor of United States Committee on Antimicrobial Susceptibility Testing (USCAST); and serves as a board member, owner, officer, or committee member of College of American Pathologists, Microbiology Resource Committee.
